Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.

Oncology letters

Fazekas J, Fürdös I, Singer J, Jensen-Jarolim E.
PMID: 27698788
Oncol Lett. 2016 Oct;12(4):2271-2276. doi: 10.3892/ol.2016.5001. Epub 2016 Aug 11.

Human epidermal growth factor receptor-2 (HER-2) is a well-established target for anticancer anticancerprecision medicine in humans. A HER-2 homologue with 92% amino acid identity has been described in canine mammary tumors, which whichis termed here as 'dog epidermal growth...

Cite
Fazekas J, Fürdös I, Singer J, et al. Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine. Oncol Lett. 2016;12(4):2271-2276doi: 10.3892/ol.2016.5001.
Fazekas, J., Fürdös, I., Singer, J., & Jensen-Jarolim, E. (2016). Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine. Oncology letters, 12(4), 2271-2276. https://doi.org/10.3892/ol.2016.5001
Fazekas, Judit, et al. "Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine." Oncology letters vol. 12,4 (2016): 2271-2276. doi: https://doi.org/10.3892/ol.2016.5001
Fazekas J, Fürdös I, Singer J, Jensen-Jarolim E. Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine. Oncol Lett. 2016 Oct;12(4):2271-2276. doi: 10.3892/ol.2016.5001. Epub 2016 Aug 11. PMID: 27698788; PMCID: PMC5038860.
Copy Download .nbib Format: NLM
Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.

Oncotarget

Fazekas-Singer J, Berroterán-Infante N, Rami-Mark C, Dumanic M, Matz M, Willmann M, Andreae F, Singer J, Wadsak W, Mitterhauser M, Jensen-Jarolim E.
PMID: 29137329
Oncotarget. 2017 Sep 15;8(47):83128-83141. doi: 10.18632/oncotarget.20914. eCollection 2017 Oct 10.

Due to large homology of human and canine EGFR, dogs suffering from spontaneous EGFR+ cancer can be considered as ideal translational models. Thereby, novel immunotherapeutic compounds can be developed for both human and veterinary patients. This study describes the...

Cite
Fazekas-Singer J, Berroterán-Infante N, Rami-Mark C, et al. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget. 2017;8(47):83128-83141doi: 10.18632/oncotarget.20914.
Fazekas-Singer, J., Berroterán-Infante, N., Rami-Mark, C., Dumanic, M., Matz, M., Willmann, M., Andreae, F., Singer, J., Wadsak, W., Mitterhauser, M., & Jensen-Jarolim, E. (2017). Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget, 8(47), 83128-83141. https://doi.org/10.18632/oncotarget.20914
Fazekas-Singer, Judit, et al. "Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials." Oncotarget vol. 8,47 (2017): 83128-83141. doi: https://doi.org/10.18632/oncotarget.20914
Fazekas-Singer J, Berroterán-Infante N, Rami-Mark C, Dumanic M, Matz M, Willmann M, Andreae F, Singer J, Wadsak W, Mitterhauser M, Jensen-Jarolim E. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials. Oncotarget. 2017 Sep 15;8(47):83128-83141. doi: 10.18632/oncotarget.20914. eCollection 2017 Oct 10. PMID: 29137329; PMCID: PMC5669955.
Copy Download .nbib Format: NLM
Electrophysiological Investigation of the Subcellular Fine Tuning of Sympathetic Neurons by Hydrogen Sulfide.

Frontiers in pharmacology

Dominguez-Rodriguez M, Drobny H, Boehm S, Salzer I.
PMID: 28824437
Front Pharmacol. 2017 Aug 04;8:522. doi: 10.3389/fphar.2017.00522. eCollection 2017.

H

Cite
Dominguez-Rodriguez M, Drobny H, Boehm S, et al. Electrophysiological Investigation of the Subcellular Fine Tuning of Sympathetic Neurons by Hydrogen Sulfide. Front Pharmacol. 2017;8:522doi: 10.3389/fphar.2017.00522.
Dominguez-Rodriguez, M., Drobny, H., Boehm, S., & Salzer, I. (2017). Electrophysiological Investigation of the Subcellular Fine Tuning of Sympathetic Neurons by Hydrogen Sulfide. Frontiers in pharmacology, 8522. https://doi.org/10.3389/fphar.2017.00522
Dominguez-Rodriguez, Manuel, et al. "Electrophysiological Investigation of the Subcellular Fine Tuning of Sympathetic Neurons by Hydrogen Sulfide." Frontiers in pharmacology vol. 8 (2017): 522. doi: https://doi.org/10.3389/fphar.2017.00522
Dominguez-Rodriguez M, Drobny H, Boehm S, Salzer I. Electrophysiological Investigation of the Subcellular Fine Tuning of Sympathetic Neurons by Hydrogen Sulfide. Front Pharmacol. 2017 Aug 04;8:522. doi: 10.3389/fphar.2017.00522. eCollection 2017. PMID: 28824437; PMCID: PMC5543101.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries